Labcorp management check

LH · Health Care · Health Care Services · CEO Adam H. Schechter

Filings as of

66
Management score, ranked 223rd of 487 · 26th of 60 in Health Care5 good · 2 to watch · 0 flaggedStrongest: clean books · Weakest: CEO cost · Best and worst run in Health Care →

Closest peers in Health Care Services

  1. 60CICigna80
  2. 126DVADaVita74
  3. 208ABBVAbbVie68
  4. 218DGXQuest Diagnostics67
  5. 223LHLabcorp66
  6. 305CVSCVS Health61

The seven checks

  • Good

    Have owners done well?

    Beat its chosen peersOwners$150Peers$148

    What $100 became since fiscal 2021

    5255th
    Detail

    $100 invested at the start of fiscal 2021 grew to $150, against $148 for the peer group the company picked itself.

  • Good

    Does pay follow performance?

    Pay rose and fell with returns20212025

    Pay actually paid $100 value, each on its own scale

    9480th
    Detail

    Over 5 years, the CEO's pay actually paid (equity valued at the share price) had a correlation of 0.88 with shareholder return. 1 means pay moved in step; below 0, the opposite way.

  • Watch

    What does the CEO cost owners?

    2.1% of net income

    $18.3m pay · $877.0m net income, FY2025

    0.1%1%3%10%
    2328th
    Detail

    $18.3m of reported pay in fiscal 2025, against $877.0m of net income.

  • Watch

    Do they own the stock?

    CEO stake ≈ 1.8 years of pay

    102,565 shares ≈ $32.9m

    0.1y1y5y20y100y

    6 mo: ▲ $0 bought · ▼ $4.8m sold

    2826th
    Detail

    The CEO holds 102,565 shares, directly or through trusts (unvested awards not counted): about 1.8 years of pay. 8 insiders sold $4.8m in the last six months and none bought. 6 of 12 sales ran on pre-arranged 10b5-1 plans.

  • Good

    Are owners being diluted?

    Share count shrinking2021 · 98m2025 · 84m

    Diluted shares −2.2% a year; flagged above +2%

    0%10%20%

    Stock pay 0.9% of revenue

    7770th
    Detail

    Diluted shares changed -2.2% a year over the last three fiscal years. Stock-based pay was 0.9% of revenue in the latest year.

  • Good

    Is leadership stable?

    7 leadership filings in 3 years

    7 filings under 8-K 5.02 in 3 years

    0101420+

    CEO: Adam H. Schechter

    9069th
    Detail

    CEO in the pay table: Adam H. Schechter. 7 filings under 8-K item 5.02 (officers or directors leaving or joining, or new pay arrangements) in the last 3 years.

  • Good

    Are the books clean?

    No red flags on file

    Since 2021

    • 0Restated
    • 0Auditor changes
    • 0Late filings
    • 010-K amended
    100100th
    Detail

    No restatements, auditor changes or late filings since 2021.

  • Reading the scores

    Each check scored 0–100 from its own figure. The tick is the Health Care median; the ordinal is the share of ranked S&P 500 companies it matches or beats.

    Hover a chart for its figures. Detail has the full reading.

Pay versus performance

From the proxy statement filed April 10, 2026.

CEO pay as reportedActually paid ⓘWhat $100 becamePeer group the company chose
−$2.3m$23.7m$49.7m$10020212022202320242025$150$148

Pay tied most to Adjusted operating income

Other key measuresAdjusted EPSAdjusted Operating IncomeRevenueRelative Total Shareholder Return

Show the figures
Fiscal yearCEOCEO payActually paidOther executives (avg)$100 becamePeersNet income
2025Adam H. Schechter$18.3m$30.1m$4.2m$150$148$877.0m
2024—$19.3m$21.3m$3.7m$163$147$746.0m
2023—$16.0m$23.8m$4.1m$160$143$418.0m
2022—$14.9m−$2.3m$4.4m$140$140$1.3bn
2021—$20.6m$49.7m$4.7m$186$143$2.4bn

Insiders and the CEO's stakeSelling

President & CEO
Adam H Schechter
Shares held
102,565
At that filing's price
≈ $32.9m
Latest Form 4
Aug 11, 2026

8 insiders sold $4.8m in the last six months and none bought. 6 of 12 sales ran on pre-arranged 10b5-1 plans.

Open-market trades by officers and directors since May 21, 2026.

  • SoldAdam H SchechterPresident & CEO · 10b5-1 plan$1.5mAug 11, 2026
  • SoldKerrii B AndersonDirector · 10b5-1 plan$954kAug 17, 2026
  • SoldBrian J CaveneyEVP, Pres of BLS, CMO & CSO$744kNov 10, 2026
  • SoldPeter J WilkinsonSVP, Chief Accounting Officer$439kAug 3, 2026

Leadership and governance on file

20222023202420252026Leadership 15Votes 5
All 15 filings

Latest shareholder vote results: May 26, 2026, including the say-on-pay vote.

Where the money went

2021–2025: $5.4bn returned to owners in buybacks and dividends, 95% of net income, and $620.9m of pay in stock.

Net incomeBuybacksDividendsStock-based payDiluted shares
$0$1.2bn$2.4bn20212022202320242025Shares98m92m88m84m84m
Show the figures
Fiscal year20212022202320242025
Revenue$13.1bn$11.9bn$12.2bn$13.0bn$14.0bn
Net income$2.4bn$1.3bn$418.0m$746.0m$877.0m
Stock-based pay$132.9m$116.8m$128.7m$116.7m$125.8m
Buybacks$1.7bn$1.1bn$1.0bn$250.1m$450.0m
Dividends—$195.2m$254.0m$243.1m$240.7m
Diluted shares98m92m88m84m84m

Educational only, not investment advice. Figures are as filed with the SEC: pay from the proxy's pay-versus-performance table, capital allocation from 10-K XBRL data, insider trades from Form 4s over the last six months, events from the last 5 years of filings. The peer group is the one the company chose. See the method.